A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB AS ADJUVANT TREATMENT FOLLOWING COMPLETE RESECTION AND PLATINUM-BASED CHEMOTHERAPY IN ADULT PATIENTS WITH EARLY-STAGE NON-SMALL CELL LUNG CANCER WITH A HIGH RISK OF RECURRENCE

被引：0
|
作者：
Miguel, Silva L. [1 ]
Pinheiro, B. [2 ]
Carvalho, P. [1 ]
Jovanoski, N. [3 ]
Belleli, R. [3 ]
Abogunrin, S. [3 ]
Alves, P. [1 ,4 ]
Araujo, A. [5 ]
Barata, F. [6 ]
Hespanhol, V [7 ]
da Luz, R. [8 ]
Borges, M. [9 ]
机构：
[1] IQVIA Portugal, Lisbon, Portugal
[2] IQVIA Portugal, Oeiras, Portugal
[3] F Hoffmann La Roche Ltd, Basel, Switzerland
[4] Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[5] Ctr Hosp Univ Santo Antonio, Porto, Portugal
[6] Ctr Hosp & Univ Coimbra, Coimbra, Portugal
[7] Ctr Hosp Univ S Joao, Porto, Portugal
[8] Ctr Hosp & Univ Lisboa Cent, Lisbon, Portugal
[9] Univ Lisbon, Lab Farmacol Clin & Terapeut, Fac Med, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE78
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [41] Identification of Stage I Non-small Cell Lung Cancer Patients at High Risk for Local Recurrence Following Sublobar Resection
    Varlotto, John M.
    Medford-Davis, Laura N.
    Recht, Abram
    Flickinger, John
    Yao, Nengliang
    Hess, Clayton
    Reed, Michael F.
    Toth, Jennifer
    Zander, Dani S.
    DeCamp, Malcolm M.
    CHEST, 2013, 143 (05) : 1365 - 1377
  • [42] COST-EFFECTIVENESS ANALYSIS OF NEOADJUVANT NIVOLUMAB PLUS PLATINUM-BASED CHEMOTHERAPY (PDC) IN RESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC) IN FRANCE: A SITUATION OF DOMINANCE
    Casabianca, P.
    Carette, J.
    Chouaid, C.
    Harris, M.
    Chartier, M.
    Sun, A.
    White, B.
    Leleu, H.
    Lucherini, S.
    Cotte, F. E.
    VALUE IN HEALTH, 2024, 27 (12) : S80 - S81
  • [43] Cost-Effectiveness of Atezolizumab for Adjuvant Treatment of Patients with Stage II-IIIA PD-L1+Non-small Cell Lung Cancer
    Das, M.
    Ogale, S.
    Johnson, A.
    Nguyen, C.
    Bhagwakar, J.
    Jovanoski, N.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S253 - S253
  • [44] Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients
    Song, Ying-Jian
    Wang, Li-Xin
    Hong, Yong-Qing
    Lu, Zheng-Hong
    Tong, Qiang
    Fang, Xiao-Zheng
    Tan, Juan
    TUMOR BIOLOGY, 2016, 37 (04) : 5285 - 5293
  • [45] Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
    Hirotsugu Kenmotsu
    Tateaki Naito
    Keita Mori
    Ryo Ko
    Akira Ono
    Kazushige Wakuda
    Hisao Imai
    Tetsuhiko Taira
    Haruyasu Murakami
    Masahiro Endo
    Toshiaki Takahashi
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 521 - 526
  • [46] Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Mori, Keita
    Ko, Ryo
    Ono, Akira
    Wakuda, Kazushige
    Imai, Hisao
    Taira, Tetsuhiko
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Toshiaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 521 - 526
  • [47] COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS
    Kourkoulas, N.
    Athanasakis, K.
    Kakouros, M.
    Skroumpelos, A.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2018, 21 : S39 - S40
  • [48] COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO THE STANDARD OF CARE FOR THE TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY IN GREECE
    Kourkoulas, N.
    Kyriopoulos, D.
    Athanasakis, K.
    VALUE IN HEALTH, 2017, 20 (09) : A439 - A439
  • [49] Clinical study of platinum-based chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer
    Zhang, Xiaotong
    Li, Longyun
    Lu, Bo
    CHEST, 2007, 132 (04) : 590S - 591S
  • [50] Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer
    Stenehjem, David D.
    Bellows, Brandon K.
    Yager, Kraig M.
    Jones, Joshua
    Kaldate, Rajesh
    Siebert, Uwe
    Brixner, Diana I.
    ONCOLOGIST, 2016, 21 (02): : 196 - 204
12345